U.S. Infectious Disease Vaccine Pipeline


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service was constructed to provide an overview of trends and developments in vaccines for infectious diseases. Challenges and trends for vaccine development as well as the clinical development by each major infectious diseases has been discussed in this research service.

Table of Contents

U.S. Infectious Disease Vaccine Pipeline, U.S. Infectious Diseases Vaccine PipelineIntroduction and ScopeTitleDisclaimerCertificationTable of ContentsIntroduction and ScopeVaccine DevelopmentClinical DevelopmentChallengesMarket TrendsVaccine Pipeline by DiseaseVaccine Pipeline By DiseaseHepatitis BHepatitis CCholeraTyphoid FeverHaemophilus Influenza Type BTuberculosisJapanese Encephalitis and West Nile VirusYellow FeverRespiratory Syncytial VirusEpstein-Barr VirusEbolaMalariaHuman PapillomavirusHuman Immunodeficiency VirusDengueVaricella ZosterGenital HerpesCytomegalovirusRabiesAnthraxMeningitisPneumoniaConclusionConclusion IntroductionConclusionAppendixAbout Frost and Sullivan

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.